Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Y H Teh

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Plant Biotechnology Journal|March 30, 2026
Beyond Starch: Towards a Scalable Potato Platform for Molecular FarmingIzabela Anna Chincinska, Dorota Sołtys-Kalina, Audrey Y-H Teh
Biotechnology and Bioengineering|September 13, 2016
Synthetic gene design-The rationale for codon optimization and implications for molecular pharming in plantsGina R Webster, Audrey Y-H Teh, Julian K-C Ma
Plant Biotechnology Journal|November 22, 2013
Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobaccoAudrey Y-H Teh, Daniel Maresch, Katja Klein, et al.
Current Pharmaceutical Design|February 12, 2013
Target product selection - where can Molecular Pharming make the difference?Mathew J Paul, Audrey Y H Teh, Richard M Twyman, et al.
Plant Molecular Biology|June 28, 2018
High-level expression of the HIV entry inhibitor griffithsin from the plastid genome and retention of biological activity in dried tobacco leavesMatthijs Hoelscher, Nadine Tiller, Audrey Y-H Teh, et al.
British Journal of Clinical Pharmacology|June 15, 2016
Recombinant biologic products versus nutraceuticals from plants - a regulatory choice?Pascal M W Drake, Tim H Szeto, Mathew J Paul, et al.
Frontiers in Plant Science|March 16, 2023
Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical useMelanie Grandits, Clemens Grünwald-Gruber, Silke Gastine, et al.
Retrovirology|June 29, 2021
Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plantsCatherine M Moore, Melanie Grandits, Clemens Grünwald-Gruber, et al.
Frontiers in Plant Science|September 26, 2022
Engineering the <i>N</i>-glycosylation pathway of <i>Nicotiana tabacum</i> for molecular pharming using CRISPR/Cas9Kathrin Göritzer, Melanie Grandits, Clemens Grünwald-Gruber, et al.
Biotechnology and Bioengineering|March 3, 2022
Multiple gene expression in plants using MIDAS-P, a versatile type II restriction-based modular expression vectorElizabeth C Pinneh, Craig J van Dolleweerd, Kathrin Göritzer, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Plant Biotechnology Journal|March 30, 2026
Beyond Starch: Towards a Scalable Potato Platform for Molecular FarmingIzabela Anna Chincinska, Dorota Sołtys-Kalina, Audrey Y-H Teh
Biotechnology and Bioengineering|September 13, 2016
Synthetic gene design-The rationale for codon optimization and implications for molecular pharming in plantsGina R Webster, Audrey Y-H Teh, Julian K-C Ma
Plant Biotechnology Journal|November 22, 2013
Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobaccoAudrey Y-H Teh, Daniel Maresch, Katja Klein, et al.
Current Pharmaceutical Design|February 12, 2013
Target product selection - where can Molecular Pharming make the difference?Mathew J Paul, Audrey Y H Teh, Richard M Twyman, et al.
Plant Molecular Biology|June 28, 2018
High-level expression of the HIV entry inhibitor griffithsin from the plastid genome and retention of biological activity in dried tobacco leavesMatthijs Hoelscher, Nadine Tiller, Audrey Y-H Teh, et al.
British Journal of Clinical Pharmacology|June 15, 2016
Recombinant biologic products versus nutraceuticals from plants - a regulatory choice?Pascal M W Drake, Tim H Szeto, Mathew J Paul, et al.
Frontiers in Plant Science|March 16, 2023
Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical useMelanie Grandits, Clemens Grünwald-Gruber, Silke Gastine, et al.
Retrovirology|June 29, 2021
Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plantsCatherine M Moore, Melanie Grandits, Clemens Grünwald-Gruber, et al.
Frontiers in Plant Science|September 26, 2022
Engineering the <i>N</i>-glycosylation pathway of <i>Nicotiana tabacum</i> for molecular pharming using CRISPR/Cas9Kathrin Göritzer, Melanie Grandits, Clemens Grünwald-Gruber, et al.
Biotechnology and Bioengineering|March 3, 2022
Multiple gene expression in plants using MIDAS-P, a versatile type II restriction-based modular expression vectorElizabeth C Pinneh, Craig J van Dolleweerd, Kathrin Göritzer, et al.
Pageof 2